Physician profile
Danielle Ferrer
NPI 1952335531
$1,616.05
in general payments reported to CMS, 2019-2025
13 companies · $36.50 in 2025
The $36.50 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $312 · 2022: $405 · 2023: $814 · 2024: $48.18 · 2025: $36.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $507.01 | 2021-2023 | Lifevest |
| Amgen INC. | $329.51 | 2021-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $162.81 | 2021-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $128.39 | 2021-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.65 | 2023 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $117.74 | 2021 | |
| Impulse Dynamics (USA) INC. | $101.97 | 2022-2023 | Optimizer |
| Pfizer INC. | $65.91 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $19.92 | 2025 | |
| Philips North America LLC | $17.62 | 2022 | |
| Boston Scientific Corporation | $16.58 | 2025 | Bodyguardian |
| Merck Sharp & Dohme LLC | $14.98 | 2023 | Verquvo |
| W. L. Gore & Associates, INC. | $12.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Ferrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.